Skip to content
Parakho

Q1 FY27, unaudited

Revenue
₹654.98 Cr
Profit after tax
₹51.22 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations654.98+34.82%2,365.46
Other income12.57+155.80%18.17
Total income667.55+36.03%2,383.63
Employee benefit expense64.88+219.14%86.58
Finance costs49.19+37.93%148.71
Depreciation & amortisation56.06+82.72%139.90
Total expenses597.86+39.72%2,129.23
Profit before tax69.68+10.87%254.40
Tax expense18.47+28.31%32.21
Profit after tax51.22+5.69%222.20
Total comprehensive income51.49+8.09%229.35
Earnings per share
Earnings per share, basic₹3.39₹15.09
Earnings per share, diluted₹3.39₹15.09

Q1 FY27 unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base unaudited, from the company’s filing with NSE. Source

FY26 from the company’s filing with NSE. Source

Earnings call

Q4 FY26

Anupam Rasayan reported its highest ever annual revenue for FY26, with consolidated revenue from operations at INR2,384 crores, up 65% year-on-year, and EBITDA margin of 23%. The company completed the acquisition of Jayhawk Fine Chemicals and announced a definitive agreement to acquire a 43.3% to 48.2% equity stake in Bliss GVS Pharma along with an open offer for up to 26% additional shares. Management described diversification away from agrochemicals, with pharma revenue growing to INR339 crores in FY26 from INR21 crores in FY22, and outlined plans to integrate Tanfac, Jayhawk and Bliss GVS Pharma into its platform strategy.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 51 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 20 Aug 2026.